Cargando…
Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis
Introduction: Steroid-refractory acute severe ulcerative colitis (ASUC) patients are at the highest risk of colectomy. Among the available options, cyclosporine and infliximab have similar efficacy but infliximab is a costly drug and cyclosporine has multiple side effects like kidney injury, neuroto...
Autores principales: | Malakar, Sayan, Kothalkar, Srikanth, Shamsul Hoda, Umair, Ghoshal, Uday C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581501/ https://www.ncbi.nlm.nih.gov/pubmed/37854768 http://dx.doi.org/10.7759/cureus.45416 |
Ejemplares similares
-
Extensive Unprovoked Thromboembolism in Steroid-Dependent Ulcerative Colitis: A Case Report
por: Arshad, Hassaan, et al.
Publicado: (2023) -
A Case of Immune Checkpoint Inhibitor Refractory Colitis Treated with Mycophenolate and High-dose Steroids
por: Alcantar, Daniel, et al.
Publicado: (2019) -
Relationship between Ulcerative Colitis and Rheumatoid Arthritis: A Review
por: Attalla, Mark G, et al.
Publicado: (2019) -
Impact of biological agents and tofacitinib for moderate-to-severe ulcerative colitis on health-related quality of life: a protocol for a network meta-analysis
por: Ma, Xueni, et al.
Publicado: (2021) -
Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis
por: Nakamura, Masanao, et al.
Publicado: (2022)